Work

A phase II multicenter study of NASOX regimen as adjuvant chemotherapy for patients with resected pancreatic ductal adenocarcinoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4230

Authors: Kuirong Jiang, Min Tu, Qianqian Wang, Nan Lv, Dong Xu, Yang Wu

Institutions: Jiangsu Province Hospital, Nanjing Medical University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162485590

Cites:

Cited by:

Related to: